Abstract
The optimal treatment of ischemic heart disease (IHD) is still at the center of a heated debate. A number of studies investigated the outcomes and risk/benefit balance of two accepted approaches to CAD, namely percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). If the general consensus on Left Main disease seems to be trending toward the equivalence of PCI with CABG, the decision about the optimal treatment of multivessel disease is more complex. For many patients with multivessel coronary artery disease, relatively well-preserved left ventricular systolic function , coronary anatomy with low complexity and no diabetes, there is a preference for PCI. For those patients with complex coronary anatomy or diabetes, there is a strong preference for CABG.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
